SANTEN PHARMACEUTICAL CO.,LTD. Logo

SANTEN PHARMACEUTICAL CO.,LTD.

A global company specializing in pharmaceuticals and medical devices for ophthalmology.

4536 | T

Overview

Corporate Details

ISIN(s):
JP3336000009
LEI:
Country:
Japan
Address:
大阪市北区大深町4番20号

Description

Santen Pharmaceutical Co., Ltd. is a global company specializing in ophthalmology. It is engaged in the research, development, manufacturing, sales, and marketing of pharmaceutical products and medical devices dedicated to eye health. The company's portfolio includes prescription and over-the-counter pharmaceuticals that address a wide range of ophthalmic conditions. Serving patients, consumers, and medical professionals in over 60 countries, Santen aims to contribute to the realization of “Happiness with Vision” by providing valuable products and services worldwide.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Select rows to enable
Date Filing Language Type / Size Actions
2025-12-15 06:37
自己株券買付状況報告書(法24条の6第1項に基づくもの)
Japanese ZIP 24.5 KB
2025-11-14 01:56
自己株券買付状況報告書(法24条の6第1項に基づくもの)
Japanese ZIP 25.9 KB
2025-11-10 07:02
確認書
Japanese ZIP 8.7 KB
2025-11-10 07:01
半期報告書-第114期(2025/04/01-2026/03/31)
Japanese ZIP 366.6 KB
2025-10-15 03:28
自己株券買付状況報告書(法24条の6第1項に基づくもの)
Japanese ZIP 24.2 KB
2025-09-12 04:58
自己株券買付状況報告書(法24条の6第1項に基づくもの)
Japanese ZIP 25.9 KB
2025-08-13 03:24
自己株券買付状況報告書(法24条の6第1項に基づくもの)
Japanese ZIP 25.8 KB
2025-07-15 04:38
自己株券買付状況報告書(法24条の6第1項に基づくもの)
Japanese ZIP 25.2 KB
2025-06-25 04:08
臨時報告書
Japanese ZIP 26.5 KB
2025-06-24 09:22
臨時報告書
Japanese ZIP 32.1 KB
2025-06-23 08:29
内部統制報告書-第113期(2024/04/01-2025/03/31)
Japanese ZIP 24.3 KB
2025-06-23 08:28
確認書
Japanese ZIP 8.5 KB
2025-06-23 08:27
有価証券報告書-第113期(2024/04/01-2025/03/31)
Japanese ZIP 2.2 MB
2025-06-13 04:35
自己株券買付状況報告書(法24条の6第1項に基づくもの)
Japanese ZIP 22.1 KB
2025-04-15 06:53
自己株券買付状況報告書(法24条の6第1項に基づくもの)
Japanese ZIP 21.3 KB

Automate Your Workflow. Get a real-time feed of all SANTEN PHARMACEUTICAL CO.,LTD. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for SANTEN PHARMACEUTICAL CO.,LTD.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for SANTEN PHARMACEUTICAL CO.,LTD. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Annexon, Inc. Logo
Clinical-stage biopharma developing complement medicines by inhibiting C1q.
United States of America
ANNX
ANTEROGEN CO., LTD. Logo
Develops and commercializes cell therapies and orphan drugs using adult stem cells.
South Korea
065660
Antibiotice S.A. Logo
Pharmaceutical firm manufacturing generic medicines, anti-infectives, and APIs.
Romania
ATB
Apellis Pharmaceuticals, Inc. Logo
Biopharmaceutical company developing therapies by targeting the complement cascade.
United States of America
APLS
Apimeds Pharmaceuticals US, Inc. Logo
Clinical-stage biopharma developing a bee venom drug and AI digital treasury solutions.
United States of America
APUS
Apogee Therapeutics, Inc. Logo
Clinical-stage biotech developing biologics for immunological and inflammatory diseases.
United States of America
APGE
Apollomics Inc. Logo
Clinical-stage biotech developing innovative oncology and combination therapies.
United States of America
APLM
Apontis Pharma AG Logo
Develops and markets fixed-dose combination drugs (Single Pills) for chronic diseases.
Germany
APPH
Applied Therapeutics, Inc. Logo
Clinical-stage biopharma developing novel drugs for rare metabolic and CNS diseases.
United States of America
APLT
Aprogen Biologics Inc. Logo
Develops and manufactures novel biologics and biosimilar antibody-based therapeutics.
South Korea
003060

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.